We used doxycycline-inducible expression of human ESE2B, the ELF5 isoform expressed in mammary gland [22], combined with ChIP-seq from MCF-7 and T47-D breast cancer cells, to search for a transcriptional mechanism that allows ELF5 to modulate estrogen-driven gene expression. Here, ELF5 is linked to breast carcinoma.